No Data
No Data
Express News | HC Wainwright & Co. Maintains Buy on Biora Therapeutics, Adjusts Price Target To $23 (1-10 Reverse Stock Split)
Biora Therapeutics Analyst Ratings
Express News | Biora Therapeutics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness Following a Q3 Earnings Miss and a Year-over-year Decline in Revenue Reported on Thursday
Biora Therapeutics | 10-Q: Q3 2024 Earnings Report
Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Express News | Highbridge Capital Management, LLC Reports 9.99% Passive Stake in Biora Therapeutics Inc as of Sept 30, 2024- SEC Filing